Related Experiment Videos
Overall symptom measurement: which approach?
1Dept of Paediatrics, Hammersmith Hospital London, UK.
Insights
Preschool wheeze symptom severity assessment lacks standardized methods, hindering clinical trial validity. Objective measures are urgently needed to accurately quantify episodes and interval symptoms for better research outcomes.
Area of Science:
- Pediatric Respiratory Medicine
- Clinical Epidemiology
Background:
- Preschool wheeze presents diverse symptoms, making severity and prevalence assessment challenging.
- Distinguishing viral-induced episodes from daily symptoms and quantifying them is often overlooked.
- Current methods for assessing symptom severity lack consensus, impacting research reliability.
Purpose of the Study:
- To highlight the need for standardized methods to assess preschool wheeze symptom severity.
- To emphasize the importance of distinguishing acute episodes from interval symptoms.
- To advocate for validation of assessment tools using objective measures.
Main Methods:
- Review of current approaches to preschool wheeze symptom assessment.
- Analysis of challenges in quantifying symptom frequency, duration, and magnitude.
- Discussion on the limitations of medication use as a severity indicator.
Main Results:
- No agreed-upon method exists for defining or quantifying preschool wheeze symptom severity.
- Medication use is an unreliable proxy for symptom severity due to lack of consensus on treatment criteria.
- Existing population questionnaires and symptom diaries lack validated objective measures.
Conclusions:
- Standardized, objective measures are crucial for accurately assessing preschool wheeze severity.
- Validated tools are urgently required for reliable clinical trials and epidemiological studies.
- Further research should focus on developing and validating objective assessment methods for preschool wheeze.
Abstract:
The syndrome of preschool wheeze includes a wide range of symptomology, measurement of which necessitates assessment of severity as well as prevalence. Most wheezing in this age group is episodic and associated with viral infections, and it is often difficult to distinguish wheeze from other lower respiratory symptoms. An overall measure of symptom severity should include the frequency, duration and magnitude both of episodes and interval symptoms. However, little attention has been paid to either the distinction of acute virus-related episodes from day-to-day symptoms, or their quantification. The type of medication used is sometimes considered as a measure of symptom severity. Since there is no consensus about either the criteria for the use of anti-inflammatory agents or their modulating effect, this practice is unreliable. Without an agreed method to define symptom severity, it is difficult to assess the validity of either population questionnaires or symptom diaries for use in clinical trials. Validation using objective measures is urgently required.